This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b ...

Data support potential of innovative gene therapy using novel RNA editing, paired with targeted AAV.ai delivery and scalable ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

Creyon Bio, Inc. (Creyon) announced a global licensing and multi-target research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of novel ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

"This partnership marks an important milestone for Creyon as we work to advance our RNA-targeted oligo therapy pipeline to the clinic for both rare and common diseases." “We are pleased to ...

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...